Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mangafodipir for prevention of oxaliplatin-induced peripheral neuropathy
2008-000198-39Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mangafodipir in peripheral neuropathy, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Worst peripheral neuropathy severity. Started Mar 2008; status: active.
02
Drugs
mangafodipir
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on 2008-000198-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000198-39.